お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は血管炎の治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは血管炎の治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の血管炎の治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは血管炎の治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に血管炎の治療市場を分類しています。本研究に含まれる主な企業は：Abbvie、Ablynx、Amgen、Anthera Pharmaceuticals、Aspen Pharmacare Holdings、Astrazeneca、Baxter、Biogen、Bristol-Myers Squibb、Celgene、Celltrion、Chemocentryx、Chugai Pharma Usa、Eisai、Eli Lilly、F. Hoffmann-La Roche、Genentech、Gilead、Glaxosmithkline、Human Genome Sciences

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Large Vasculitis Treatment
    Medium Vasculitis Treatment
    Small Vasculitis Treatment

用途別の市場セグメント：
    Hospitals And Clinics
    Diagnosis Center
    Research Institutes
    Others

本レポートの詳細内容
世界の血管炎の治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、血管炎の治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の血管炎の治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の血管炎の治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、血管炎の治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

血管炎の治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：血管炎の治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：血管炎の治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章血管炎の治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：血管炎の治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：血管炎の治療の主要企業の概要を提供し、製品の説明と仕様、血管炎の治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Vasculitis is a general term that refers to inflammation of blood vessels. When blood vessels become inflamed, they may become weakened, stretch, and either increase in size or become narrow -- even to the point of closing entirely.    Vasculitis can affect people of all ages, but there are types of vasculitis that occur in certain age groups more often than others.
Market Analysis and Insights: Global Vasculitis Treatment Market
The global Vasculitis Treatment market is projected to grow from US$ 425.5 million in 2024 to US$ 531 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.8% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Vasculitis Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Vasculitis Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Vasculitis Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vasculitis Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Vasculitis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Vasculitis Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbvie, Ablynx, Amgen, Anthera Pharmaceuticals, Aspen Pharmacare Holdings, Astrazeneca, Baxter, Biogen and Bristol-Myers Squibb, etc.

Market Segmentation
By Company
    Abbvie
    Ablynx
    Amgen
    Anthera Pharmaceuticals
    Aspen Pharmacare Holdings
    Astrazeneca
    Baxter
    Biogen
    Bristol-Myers Squibb
    Celgene
    Celltrion
    Chemocentryx
    Chugai Pharma Usa
    Eisai
    Eli Lilly
    F. Hoffmann-La Roche
    Genentech
    Gilead
    Glaxosmithkline
    Human Genome Sciences

Segment by Type
    Large Vasculitis Treatment
    Medium Vasculitis Treatment
    Small Vasculitis Treatment

Segment by Application
    Hospitals And Clinics
    Diagnosis Center
    Research Institutes
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Vasculitis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vasculitis Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vasculitis Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Vasculitis Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Large Vasculitis Treatment
    Table 3. Key Players of Medium Vasculitis Treatment
    Table 4. Key Players of Small Vasculitis Treatment
    Table 5. Global Vasculitis Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Vasculitis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Vasculitis Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Vasculitis Treatment Market Share by Region (2019-2024)
    Table 9. Global Vasculitis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Vasculitis Treatment Market Share by Region (2025-2030)
    Table 11. Vasculitis Treatment Market Trends
    Table 12. Vasculitis Treatment Market Drivers
    Table 13. Vasculitis Treatment Market Challenges
    Table 14. Vasculitis Treatment Market Restraints
    Table 15. Global Vasculitis Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Vasculitis Treatment Revenue Share by Players (2019-2024)
    Table 17. Global Top Vasculitis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vasculitis Treatment as of 2023)
    Table 18. Global Vasculitis Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Vasculitis Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Vasculitis Treatment, Headquarters and Area Served
    Table 21. Global Key Players of Vasculitis Treatment, Product and Application
    Table 22. Global Key Players of Vasculitis Treatment, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Vasculitis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Vasculitis Treatment Revenue Market Share by Type (2019-2024)
    Table 26. Global Vasculitis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Vasculitis Treatment Revenue Market Share by Type (2025-2030)
    Table 28. Global Vasculitis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Vasculitis Treatment Revenue Share by Application (2019-2024)
    Table 30. Global Vasculitis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Vasculitis Treatment Revenue Share by Application (2025-2030)
    Table 32. North America Vasculitis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Vasculitis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Vasculitis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Vasculitis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Vasculitis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Vasculitis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Vasculitis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Vasculitis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Vasculitis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Vasculitis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Vasculitis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Vasculitis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Vasculitis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Vasculitis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Vasculitis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Vasculitis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Vasculitis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Vasculitis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Vasculitis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Vasculitis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Vasculitis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Vasculitis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Vasculitis Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Vasculitis Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Vasculitis Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Vasculitis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Vasculitis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Vasculitis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Vasculitis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Vasculitis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Vasculitis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Vasculitis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Abbvie Company Details
    Table 65. Abbvie Business Overview
    Table 66. Abbvie Vasculitis Treatment Product
    Table 67. Abbvie Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 68. Abbvie Recent Developments
    Table 69. Ablynx Company Details
    Table 70. Ablynx Business Overview
    Table 71. Ablynx Vasculitis Treatment Product
    Table 72. Ablynx Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 73. Ablynx Recent Developments
    Table 74. Amgen Company Details
    Table 75. Amgen Business Overview
    Table 76. Amgen Vasculitis Treatment Product
    Table 77. Amgen Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 78. Amgen Recent Developments
    Table 79. Anthera Pharmaceuticals Company Details
    Table 80. Anthera Pharmaceuticals Business Overview
    Table 81. Anthera Pharmaceuticals Vasculitis Treatment Product
    Table 82. Anthera Pharmaceuticals Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 83. Anthera Pharmaceuticals Recent Developments
    Table 84. Aspen Pharmacare Holdings Company Details
    Table 85. Aspen Pharmacare Holdings Business Overview
    Table 86. Aspen Pharmacare Holdings Vasculitis Treatment Product
    Table 87. Aspen Pharmacare Holdings Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 88. Aspen Pharmacare Holdings Recent Developments
    Table 89. Astrazeneca Company Details
    Table 90. Astrazeneca Business Overview
    Table 91. Astrazeneca Vasculitis Treatment Product
    Table 92. Astrazeneca Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 93. Astrazeneca Recent Developments
    Table 94. Baxter Company Details
    Table 95. Baxter Business Overview
    Table 96. Baxter Vasculitis Treatment Product
    Table 97. Baxter Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 98. Baxter Recent Developments
    Table 99. Biogen Company Details
    Table 100. Biogen Business Overview
    Table 101. Biogen Vasculitis Treatment Product
    Table 102. Biogen Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 103. Biogen Recent Developments
    Table 104. Bristol-Myers Squibb Company Details
    Table 105. Bristol-Myers Squibb Business Overview
    Table 106. Bristol-Myers Squibb Vasculitis Treatment Product
    Table 107. Bristol-Myers Squibb Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 108. Bristol-Myers Squibb Recent Developments
    Table 109. Celgene Company Details
    Table 110. Celgene Business Overview
    Table 111. Celgene Vasculitis Treatment Product
    Table 112. Celgene Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 113. Celgene Recent Developments
    Table 114. Celltrion Company Details
    Table 115. Celltrion Business Overview
    Table 116. Celltrion Vasculitis Treatment Product
    Table 117. Celltrion Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 118. Celltrion Recent Developments
    Table 119. Chemocentryx Company Details
    Table 120. Chemocentryx Business Overview
    Table 121. Chemocentryx Vasculitis Treatment Product
    Table 122. Chemocentryx Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 123. Chemocentryx Recent Developments
    Table 124. Chugai Pharma Usa Company Details
    Table 125. Chugai Pharma Usa Business Overview
    Table 126. Chugai Pharma Usa Vasculitis Treatment Product
    Table 127. Chugai Pharma Usa Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 128. Chugai Pharma Usa Recent Developments
    Table 129. Eisai Company Details
    Table 130. Eisai Business Overview
    Table 131. Eisai Vasculitis Treatment Product
    Table 132. Eisai Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 133. Eisai Recent Developments
    Table 134. Eli Lilly Company Details
    Table 135. Eli Lilly Business Overview
    Table 136. Eli Lilly Vasculitis Treatment Product
    Table 137. Eli Lilly Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 138. Eli Lilly Recent Developments
    Table 139. F. Hoffmann-La Roche Company Details
    Table 140. F. Hoffmann-La Roche Business Overview
    Table 141. F. Hoffmann-La Roche Vasculitis Treatment Product
    Table 142. F. Hoffmann-La Roche Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 143. F. Hoffmann-La Roche Recent Developments
    Table 144. Genentech Company Details
    Table 145. Genentech Business Overview
    Table 146. Genentech Vasculitis Treatment Product
    Table 147. Genentech Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 148. Genentech Recent Developments
    Table 149. Gilead Company Details
    Table 150. Gilead Business Overview
    Table 151. Gilead Vasculitis Treatment Product
    Table 152. Gilead Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 153. Gilead Recent Developments
    Table 154. Glaxosmithkline Company Details
    Table 155. Glaxosmithkline Business Overview
    Table 156. Glaxosmithkline Vasculitis Treatment Product
    Table 157. Glaxosmithkline Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 158. Glaxosmithkline Recent Developments
    Table 159. Human Genome Sciences Company Details
    Table 160. Human Genome Sciences Business Overview
    Table 161. Human Genome Sciences Vasculitis Treatment Product
    Table 162. Human Genome Sciences Revenue in Vasculitis Treatment Business (2019-2024) & (US$ Million)
    Table 163. Human Genome Sciences Recent Developments
    Table 164. Research Programs/Design for This Report
    Table 165. Key Data Information from Secondary Sources
    Table 166. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Vasculitis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Vasculitis Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Large Vasculitis Treatment Features
    Figure 4. Medium Vasculitis Treatment Features
    Figure 5. Small Vasculitis Treatment Features
    Figure 6. Global Vasculitis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Vasculitis Treatment Market Share by Application: 2023 VS 2030
    Figure 8. Hospitals And Clinics Case Studies
    Figure 9. Diagnosis Center Case Studies
    Figure 10. Research Institutes Case Studies
    Figure 11. Others Case Studies
    Figure 12. Vasculitis Treatment Report Years Considered
    Figure 13. Global Vasculitis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Vasculitis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Vasculitis Treatment Market Share by Region: 2023 VS 2030
    Figure 16. Global Vasculitis Treatment Market Share by Players in 2023
    Figure 17. Global Top Vasculitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vasculitis Treatment as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Vasculitis Treatment Revenue in 2023
    Figure 19. North America Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Vasculitis Treatment Market Share by Type (2019-2030)
    Figure 21. North America Vasculitis Treatment Market Share by Application (2019-2030)
    Figure 22. North America Vasculitis Treatment Market Share by Country (2019-2030)
    Figure 23. United States Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Vasculitis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Vasculitis Treatment Market Share by Type (2019-2030)
    Figure 27. Europe Vasculitis Treatment Market Share by Application (2019-2030)
    Figure 28. Europe Vasculitis Treatment Market Share by Country (2019-2030)
    Figure 29. Germany Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Vasculitis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Vasculitis Treatment Market Share by Type (2019-2030)
    Figure 37. China Vasculitis Treatment Market Share by Application (2019-2030)
    Figure 38. Asia Vasculitis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Vasculitis Treatment Market Share by Type (2019-2030)
    Figure 40. Asia Vasculitis Treatment Market Share by Application (2019-2030)
    Figure 41. Asia Vasculitis Treatment Market Share by Region (2019-2030)
    Figure 42. Japan Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Vasculitis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Vasculitis Treatment Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Vasculitis Treatment Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Vasculitis Treatment Market Share by Country (2019-2030)
    Figure 52. Brazil Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Vasculitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Abbvie Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 59. Ablynx Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 60. Amgen Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 61. Anthera Pharmaceuticals Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 62. Aspen Pharmacare Holdings Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 63. Astrazeneca Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 64. Baxter Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 65. Biogen Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 67. Celgene Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 68. Celltrion Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 69. Chemocentryx Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 70. Chugai Pharma Usa Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 71. Eisai Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 72. Eli Lilly Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 73. F. Hoffmann-La Roche Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 74. Genentech Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 75. Gilead Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 76. Glaxosmithkline Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 77. Human Genome Sciences Revenue Growth Rate in Vasculitis Treatment Business (2019-2024)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed